Home › Funds › Grantham, Mayo, Van Otterloo & Co. LLC › JNJ

Grantham, Mayo, Van Otterloo & Co. LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Grantham, Mayo, Van Otterloo & Co. LLC reported holding 6,956,949 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.84B, representing 3.96% of its reported portfolio and ranking #6 among its reported holdings. Grantham, Mayo, Van Otterloo & Co. LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.96M sh
Reported value held$1.84B
Portfolio Weight3.96%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Grantham, Mayo, Van Otterloo & Co. LLC's JNJ position evolved

Grantham, Mayo, Van Otterloo & Co. LLC first disclosed a stake in JNJ in Q3 2023 at 3,744,857 shares (US$583.3M). The position peaked in Q3 2026 at 6,956,949 shares, worth US$1.84B. Across 13 filings, Grantham, Mayo, Van Otterloo & Co. LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,956,949 shares valued at US$1.84B — a reduction of -153,184 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.74M $583.26M New
Q4 2023 3.99M $624.82M Add
Q1 2024 4.83M $763.67M Add
Q2 2024 6.02M $880.52M Add
Q3 2024 6.29M $1.02B Add
Q4 2024 6.36M $919.82M Add
Q1 2025 6.81M $1.13B Add
Q2 2025 6.55M $1.00B Reduce
Q3 2025 6.82M $1.26B Add
Q4 2025 7.09M $1.47B Add
Q1 2026 7.28M $1.78B Add
Q2 2026 7.11M $1.81B Reduce
Q3 2026 6.96M $1.84B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Grantham, Mayo, Van Otterloo & Co. LLC held JNJ?

Grantham, Mayo, Van Otterloo & Co. LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Grantham, Mayo, Van Otterloo & Co. LLC's current position in JNJ?

As of Q3 2026, Grantham, Mayo, Van Otterloo & Co. LLC holds 6.96M shares of JNJ (JOHNSON & JOHNSON), valued at $1.84B, representing 3.96% of its reported portfolio and ranking #6.

Has Grantham, Mayo, Van Otterloo & Co. LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Grantham, Mayo, Van Otterloo & Co. LLC reduced its position in JNJ. The position peaked in Q3 2026 at 6.96M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.